Stocks and Investing Stocks and Investing
Sun, September 20, 2020
Fri, September 18, 2020

Brian Abrahams Maintained (BIIB) at Hold with Decreased Target to $277 on, Sep 18th, 2020


Published on 2024-10-27 13:27:28 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $284 to $277 on, Sep 18th, 2020.

Brian has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Downgraded from Buy to Hold and Decreased Target to $280 on, Monday, June 22nd, 2020
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $297 on, Tuesday, June 9th, 2020


These are the ratings of the 3 analyists that currently disagree with Brian


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Buy and Increased Target to $357 on, Monday, July 27th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020
Contributing Sources